» Authors » Lihuang Zha

Lihuang Zha

Explore the profile of Lihuang Zha including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 216
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng B, Zha L, Juaiti M, Lin W, Zhou X, Ou Z, et al.
J Am Heart Assoc . 2025 Feb; 14(4):e038815. PMID: 39921509
Background: Inflammatory arthritis is recognized to increase cardiovascular disease risk, but its association with degenerative aortic stenosis is not well understood. Methods: This prospective cohort study used participants from the...
2.
Liang B, Lin W, Tang Y, Li T, Chen Q, Zhang W, et al.
iScience . 2024 Oct; 27(10):111036. PMID: 39435142
Pulmonary arterial hypertension (PAH) is a life-threatening disease induced by abnormal activation of pulmonary adventitial fibroblasts (PAFs) in the early stage. The association between selenium deficiency and PAH is not...
3.
Liang B, Tang Y, Chen Q, Zhong J, Peng B, Sun J, et al.
Heliyon . 2024 Jul; 10(13):e33599. PMID: 39040401
Background: The timing of central venous pressure (CVP) measurement may play a crucial role in heart failure management, yet no studies have explored this aspect. Methods: Clinical information pertaining to...
4.
Tang Y, Liu Z, Chen Q, Juaiti M, Yu Z, Liang B, et al.
Aging Cell . 2024 May; 23(8):e14198. PMID: 38739369
The relationship between sarcopenia and the long-term risk of atrial fibrillation (AF) remains unclear. This study recruited a large prospective Caucasian cohort from the UK Biobank. Participants were assessed at...
5.
Liang B, Tang Y, Li S, Zhou X, Juaiti M, Zha L, et al.
Heart Lung . 2024 May; 67:191-200. PMID: 38734535
Background: It is essential to assess the risk stratification of patients with aortic stenosis (AS). Objective: To clarify the predictive value of red blood cell distribution width (RDW) in AS...
6.
Juaiti M, Feng Y, Tang Y, Liang B, Zha L, Yu Z
Heliyon . 2024 Apr; 10(8):e29587. PMID: 38660271
Background: Pulmonary arterial hypertension (PAH) represents a substantial global risk to human health. This study aims to identify diagnostic biomarkers for PAH and assess their association with the immune microenvironment...
7.
Liang B, Zha L, Peng B, Chen Q, Juaiti M, Zeng X, et al.
Thromb Haemost . 2024 Apr; 124(10):948-957. PMID: 38608711
Background:  The Life's Essential 8 (LE8) score, recently proposed by the American Heart Association, represents a new paradigm for evaluating cardiovascular health (CVH). We aimed to explore the association between...
8.
Zhou X, Liang B, Lin W, Zha L
Comput Biol Med . 2024 Mar; 173:108372. PMID: 38552277
Background: Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by abnormal early activation of pulmonary arterial smooth muscle cells (PASMCs), yet the underlying mechanisms remain to be elucidated. Methods:...
9.
Zeng X, Sun J, Li F, Peng L, Zhang C, Jiang X, et al.
Antioxid Redox Signal . 2024 Jan; 40(16-18):906-925. PMID: 38251672
No abstract available.
10.
Zhang W, Lin W, Zeng X, Zhang M, Chen Q, Tang Y, et al.
Aging Dis . 2023 May; 14(5):1927-1944. PMID: 37196106
Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disease with unclear underlying molecular mechanisms and limited therapeutic options. This study aimed to explore the role of core fucosylation and the...